azathioprine has been researched along with Communicable Diseases in 19 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 11 (57.89) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scott, FI | 1 |
| Vajravelu, RK | 1 |
| Bewtra, M | 1 |
| Mamtani, R | 1 |
| Lee, D | 1 |
| Goldberg, DS | 1 |
| Lewis, JD | 1 |
| Takatsu, N | 1 |
| Matsui, T | 1 |
| Murakami, Y | 1 |
| Ishihara, H | 1 |
| Hisabe, T | 1 |
| Nagahama, T | 1 |
| Maki, S | 1 |
| Beppu, T | 1 |
| Takaki, Y | 1 |
| Hirai, F | 1 |
| Yao, K | 1 |
| Cotter, PB | 1 |
| Weiter, JJ | 1 |
| Wadström, J | 1 |
| Brekke, B | 1 |
| Wramner, L | 1 |
| Ekberg, H | 1 |
| Tydén, G | 1 |
| Reichenspurner, H | 1 |
| Dienemann, H | 1 |
| Rihl, M | 1 |
| Wagner, F | 1 |
| Meiser, BM | 1 |
| Kur, F | 1 |
| Hammer, C | 1 |
| Forst, H | 1 |
| Kreuzer, E | 1 |
| Reichart, B | 1 |
| Pham, SM | 1 |
| Kormos, RL | 1 |
| Kawai, A | 1 |
| Murali, S | 1 |
| Hattler, BG | 1 |
| Demetris, AJ | 1 |
| Griffith, BP | 1 |
| Rossi, G | 1 |
| Reggiani, P | 1 |
| Orsenigo, R | 1 |
| Leoni, L | 1 |
| Caccamo, L | 1 |
| Doglia, M | 1 |
| Gatti, S | 1 |
| Maggi, U | 1 |
| Paone, G | 1 |
| Galmarini, D | 1 |
| Fassati, LR | 1 |
| Zuckermann, A | 1 |
| Birsan, T | 1 |
| Thaghavi, S | 1 |
| Artemiou, O | 1 |
| Kupilik, N | 1 |
| Dekan, G | 1 |
| Wolner, E | 1 |
| Klepetko, W | 1 |
| Van Buren, D | 1 |
| Payne, J | 1 |
| Geevarghese, S | 1 |
| MacDonell, R | 1 |
| Chapman, W | 1 |
| Wright, JK | 1 |
| Helderman, JH | 1 |
| Richie, R | 1 |
| Pinson, CW | 1 |
| Spillner, J | 1 |
| Kohnle, M | 1 |
| Albrecht, KH | 1 |
| Heemann, U | 1 |
| Tsai, MK | 1 |
| Lee, PH | 1 |
| Hu, RH | 1 |
| Lee, CJ | 1 |
| Tisone, G | 1 |
| Angelico, M | 1 |
| Orlando, G | 1 |
| Palmieri, GP | 1 |
| Strati, F | 1 |
| Di Paolo, D | 1 |
| Casciani, CU | 1 |
| Esmeraldo, RM | 1 |
| Donadi, MO | 1 |
| Oliveira, ML | 1 |
| Ponte, CN | 1 |
| Pinheiro, PM | 1 |
| Kirkman, RL | 1 |
| Shapiro, ME | 1 |
| Carpenter, CB | 1 |
| McKay, DB | 1 |
| Milford, EL | 1 |
| Ramos, EL | 1 |
| Tilney, NL | 1 |
| Waldmann, TA | 1 |
| Zimmerman, CE | 1 |
| Strom, TB | 1 |
| Takahashi, K | 1 |
| Yagisawa, T | 1 |
| Teraoka, S | 1 |
| Tanabe, K | 1 |
| Ebihara, K | 1 |
| Fuchinoue, S | 1 |
| Honda, H | 1 |
| Toma, T | 1 |
| Agishi, T | 1 |
| Ota, K | 1 |
| Oka, T | 1 |
| Omori, Y | 1 |
| Aikawa, I | 1 |
| Yasumura, T | 1 |
| Yoshimura, N | 1 |
| Yoshida, T | 1 |
| Kozaki, M | 1 |
| Hirano, T | 1 |
| Oka, K | 1 |
| Honma, M | 1 |
| Kang, X | 1 |
| Sakurai, E | 1 |
| Tamaki, T | 1 |
| Tamaki, I | 1 |
| Salaman, J | 1 |
| Abbud-Filho, M | 1 |
| Ramalho, HJ | 1 |
| Barberato, JB | 1 |
| Corrente, JE | 1 |
| Salgueiro, MC | 1 |
| Mazzetto, MR | 1 |
| Bezas, AG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study of Compliance, Practice Patterns, and Barriers REgarding Established National Screening Programs for Barrett's Esophagus: SCREEN-BE[NCT04408105] | 725 participants (Actual) | Observational | 2020-02-19 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 trials available for azathioprine and Communicable Diseases
| Article | Year |
|---|---|
Triple versus quadruple induction immunosuppression in pancreas transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Drug Res | 1995 |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Coronary Disease; Cyclosporine; Dr | 1996 |
Mycophenolate mofetil in lung transplantation.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Cyclosporine; Dr | 1998 |
Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
Topics: Adult; Analysis of Variance; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Diabetes | 1998 |
Anti-LFA-1 monoclonal antibody in renal transplantation: renal function, infections, and other complications.
Topics: Antibodies, Monoclonal; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Drug Therapy, | 1998 |
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
Topics: Antibodies, Monoclonal; Azathioprine; Communicable Diseases; Cyclosporins; Drug Therapy, Combination | 1991 |
Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation.
Topics: Azathioprine; Clinical Trials as Topic; Communicable Diseases; Cyclosporins; Drug Administration Sch | 1989 |
Cyclosporine mono-drug therapy.
Topics: Azathioprine; Communicable Diseases; Cyclosporins; Drug Therapy, Combination; Graft Survival; Humans | 1988 |
11 other studies available for azathioprine and Communicable Diseases
| Article | Year |
|---|---|
The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model.
Topics: Adult; Age Factors; Aged; Azathioprine; Communicable Diseases; Crohn Disease; Drug Therapy, Combinat | 2015 |
Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
Topics: Adult; Alopecia; Aminosalicylic Acids; Anti-Inflammatory Agents; Asian People; Azathioprine; Chemica | 2009 |
Retinopathy in a patient with systemic lupus erythematosus.
Topics: Adult; Azathioprine; Communicable Diseases; Female; Humans; Lupus Erythematosus, Systemic; Prednison | 1982 |
Pulmonary rejection diagnosis after lung and heart-lung transplantation.
Topics: Azathioprine; Communicable Diseases; Cyclosporine; Diagnosis, Differential; Graft Rejection; Heart-L | 1993 |
Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
Topics: Administration, Oral; Adult; Azathioprine; Communicable Diseases; Female; Follow-Up Studies; Graft R | 1998 |
Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression.
Topics: Azathioprine; Cause of Death; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Graft | 1998 |
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids.
Topics: Adult; Azathioprine; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Female; Humans; | 1999 |
Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
Topics: Adolescent; Adult; Aged; Azathioprine; Communicable Diseases; Cyclosporine; Dose-Response Relationsh | 1999 |
Infectious diseases in 450 kidney transplant recipients treated with cyclosporine in a single center.
Topics: Azathioprine; Communicable Diseases; Cyclosporins; Humans; Immunosuppression Therapy; Kidney Transpl | 1989 |
Postoperative endogenous serum cortisol levels as an index of acute rejection and severe infection in renal allograft recipients.
Topics: Azathioprine; Biomarkers; Communicable Diseases; Cyclosporins; Graft Rejection; Humans; Hydrocortiso | 1989 |
A prospective study of conversion from cyclosporine to azathioprine: comparison of clinical and morphologic findings.
Topics: Azathioprine; Communicable Diseases; Cyclosporins; Drug Administration Schedule; Graft Rejection; Gr | 1988 |